BlackRock Institutional Trust Company, N.A. - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 193 filers reported holding NPS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$96,303,000
+34.2%
2,692,274
-2.5%
0.02%
+25.0%
Q3 2014$71,760,000
-20.8%
2,759,995
+0.6%
0.01%
-20.0%
Q2 2014$90,638,000
+10.7%
2,742,449
+0.2%
0.02%
+7.1%
Q1 2014$81,903,000
+1.3%
2,736,471
+2.8%
0.01%0.0%
Q4 2013$80,820,000
-3.6%
2,662,069
+1.0%
0.01%
-12.5%
Q3 2013$83,851,000
+105.8%
2,636,003
-2.2%
0.02%
+100.0%
Q2 2013$40,739,0002,696,1380.01%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,839,263$27,791,0009.88%
Broadfin Capital, LLC 1,696,754$25,638,0005.02%
HARVEY CAPITAL MANAGEMENT INC 1,057,800$15,982,0004.96%
ArrowMark Colorado Holdings LLC 578,750$8,745,0002.35%
FCG ADVISORS, LLC 140,805$2,128,0001.73%
EMERALD MUTUAL FUND ADVISERS TRUST 600,471$9,073,0001.54%
OAK RIDGE INVESTMENTS LLC 2,782,714$42,047,0001.32%
Lisanti Capital Growth, LLC 139,340$2,510,0001.20%
EMERALD ADVISERS, LLC 1,193,198$18,029,0001.10%
SECTORAL ASSET MANAGEMENT INC 2,302,428$34,790,0001.03%
View complete list of NPS PHARMACEUTICALS INC shareholders